Request Appointment
161 Fort Washington AveFl 9New York, NY 10032
Overview of Dr. Izar
Dr. Benjamin Izar is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Giessen Faculty of Medicine and has been in practice 7 years. He is one of 121 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 372 doctors at New York-Presbyterian Hospital who specialize in Oncology. He also speaks multiple languages, including German. He has more than 80 publications and over 500 citings.
Education & Training
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2011 - 2012
University of Giessen Faculty of MedicineClass of 2010
Certifications & Licensure
NY State Medical License 2019 - 2027
MA State Medical License 2014 - 2021
Publications & Presentations
PubMed
- Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases.Irene Soler-Sáez, Alcida Karz, Marta R Hidalgo, Borja Gómez-Cabañes, Adolfo López-Cerdán
The Journal of Investigative Dermatology. 2025-05-01 - The SWI/SNF PBAF complex facilitates REST occupancy at repressive chromatin.Elena Grossi, Christie B Nguyen, Saul Carcamo, Valentina Kirigin Callaú, Shannon Moran
Molecular Cell. 2025-04-16 - Pan-cancer human brain metastases atlas at single-cell resolution.Xudong Xing, Jian Zhong, Jana Biermann, Hao Duan, Xinyu Zhang
Cancer Cell. 2025-04-07
Press Mentions
Expanding Research on Dormant Cancer Cells Aims to Prevent MetastasisApril 10th, 2025- New Insights into Melanoma Brain MetastasesJuly 15th, 2022
- New Insights into Melanoma Brain MetastasesJuly 15th, 2022
- Join now to see all
Grant Support
- Multi-cellular interactions defining the human brain metastatic nicheCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028
- The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- Mechanisms of liver metastasis and associated resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2026
- Mechanisms of liver metastasis and associated resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2026
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
